Everolimus Plus Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma
Clinical trial NCT00869999 · COMPLETED
Trial details
- NCT number
- NCT00869999
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-01
- Primary completion
- 2011-11-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.